Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Dynavax Technologies

Dynavax Technologies reported $63.77M in EBIT for its fiscal quarter ending in December of 2022.

Ebit Change
Aceragen Inc IDRA:US USD -6303000 2.61M
Amgen AMGN:US USD 2.1B 129M
AstraZeneca AZN:LN USD 2.78B 943M
Biogen BIIB:US USD 574.4M 304.3M
BioMarin Pharmaceutical BMRN:US USD 61.45M 85.95M
Bristol-Myers Squibb BMY:US USD 3B 686M
Chimerix CMRX:US USD -24218000 404K
Gilead Sciences GILD:US USD 1.71B 558M
Glaxosmithkline GSK:US GBP 1.92B 483M
Merck & Co MRK:US USD 4.41B 1.14B
Minerva Neurosciences NERV:US USD -5348520 278.79K
Nektar Therapeutics NKTR:US USD -37016000 3.87M
Neurocrine Biosciences NBIX:US USD 29.7M 73.7M
Novartis NOVN:VX USD 3.23B 123M
Pfizer PFE:US USD 6.91B 1.1B
Regeneron Pharmaceuticals REGN:US USD 1B 174M
Roche Holding ROG:VX CHF 8.49B 3.05B
Sarepta Therapeutics SRPT:US USD -138088000 31.26M
TG Therapeutics TGTX:US USD -36992000 15.07M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M